Charles River Laboratories International (CRL) Change in Cash (2009 - 2026)
Charles River Laboratories International (CRL) posted Change in Cash of $42.4 million for Q2 2026, up 338.14% on a QoQ basis from -$17.8 million in Q1 2026, and up 190.19% year-over-year from $14.6 million in Q2 2025.
Analysis
Charles River Laboratories International (CRL) Change in Cash (2009 - 2026) Analysis & Trends
Charles River Laboratories International has reported Change in Cash for 18 years, with the latest figure at $42.4 million in Q2 2026.
- On a quarterly basis, Change in Cash rose 190.19% year-over-year to $42.4 million in Q2 2026; TTM through Jun 2026 was $55.8 million, a 1394.67% increase from a year earlier, with the FY2025 full-year figure at $10.4 million, up 113.21% from the prior year.
- Change in Cash was $42.4 million for Q2 2026 at Charles River Laboratories International, up from -$17.8 million in the prior quarter.
- The five-year high for Change in Cash was $118.9 million in Q4 2023, with the low at -$157.5 million in Q2 2024.
- Average Change in Cash over 5 years is -$318500.0, with a median of -$1.5 million recorded in 2022.
- The largest YoY upside for Change in Cash was 267.23% in 2024 against a maximum downside of 138085.09% in 2024.
- Over 5 years, Change in Cash stood at $45.0 million in 2022, then jumped by 163.93% to $118.9 million in 2023, then plunged by 105.11% to -$6.1 million in 2024, then surged by 211.65% to $6.8 million in 2025, then soared by 525.35% to $42.4 million in 2026.
- The last three Change in Cash figures came in at $42.4 million (Q2 2026), -$17.8 million (Q1 2026), and $6.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | -38.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | -149.99 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 928.39 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 42.38 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 21.10 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -16.65 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -514,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -2.71 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -3.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | 42.38 Mn |
| Mar 28, 2026 | -17.80 Mn |
| Dec 27, 2025 | 6.78 Mn |
| Sep 27, 2025 | 24.48 Mn |
| Jun 28, 2025 | -46.99 Mn |
| Mar 29, 2025 | 26.16 Mn |
| Dec 28, 2024 | -6.07 Mn |
| Sep 28, 2024 | 30.64 Mn |
| Jun 29, 2024 | -157.53 Mn |
| Mar 30, 2024 | 54.06 Mn |
| Dec 30, 2023 | 118.86 Mn |
| Sep 30, 2023 | -43.16 Mn |
| Jul 1, 2023 | -114,000.00 |
| Apr 1, 2023 | -32.32 Mn |
| Dec 31, 2022 | 45.04 Mn |
| Sep 24, 2022 | -11.03 Mn |
| Jun 25, 2022 | -36.19 Mn |
| Mar 26, 2022 | -2.92 Mn |
| Dec 25, 2021 | 19.81 Mn |
| Sep 25, 2021 | -985,000.00 |